Staar Surgical's ICL
This article was originally published in The Gray Sheet
Executive Summary
Foldable implantable contact lens system Phase III clinical trial enrollment for treatment of myopia is completed Oct. 25. The 278-patient, Phase III clinical trial included patients with -3 diopters to -20 diopters of myopia. Data for 311 eyes has been collected to date, showing a 93% drop in average diopters of myopia from 10.4 D to 0.7 D one week-post-op. Visual acuity also improved, with 82% of patients seeing 20/40 or better. Results were shown to be stable for up to one year